4Nimish Vakil M D F A Cg, Sander Vvan Zanten M D, Peter KahrilasM D, et al. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus[ J ] .Am J Gastroenterol, 2006,101 : 1900-1920. 被引量：1
5Harris RA, Kuppermann M, Richter JE.Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition[ J ] .Am J Med, 1997,102: 78-88. 被引量：1
6Savarino V, Di Mario F, Scarpignato C.Proton pump inhibitors in GORD An overview of their pharmacology, efficaey and safety[ J ]. Pharmacol Res, 2009,59 : 135-153. 被引量：1
7Wikhmd I, Talley NJ.Update on health related quality of life in patients with gastroesophageal reflux disease[ J ] .Expert Rev Pharmacoeconomics Outcomes Res, 2003,3 : 341-350. 被引量：1
8Fass R. Ep idem iology and p athophysio logy of syrup tomat ic gastroesophageal reflux disease[J] . Am J Gastroentero, 2003, 98 (64) : S2-7. 被引量：1
9Gislason T,Janson C, Vermeire P, et al. Respiratory symptoms and noctumal gastroesophageal reflux: a populmion- based study of young adult in three European countries.Chest, 2002,121 : 158-163. 被引量：1
10Ringel Y, Drossman DA, Dyson T, et al. Characterization of physiological and psychological factors in functional esophageal disorders (FED) . Gastroenterology, 2004, 126 (4 Suppl 2) A28. 被引量：1
